NCT03131830 is a clinical trial of Online-based questionnaire in Delivery Mode, sponsored by University Hospital Tuebingen.

Who is sponsoring NCT03131830?

NCT03131830 is sponsored by University Hospital Tuebingen.

What drugs are being tested in NCT03131830?

Interventions in NCT03131830: Online-based questionnaire.

What condition does NCT03131830 study?

NCT03131830 studies Delivery Mode.

Is NCT03131830 still recruiting?

NCT03131830 is currently completed. Last updated 12 February 2026.

Last reviewed 2026-02-12 · How we verify

NCT03131830

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Individual Choice of Delivery Mode

Completed Last updated 12 February 2026

What this trial tests

trial testing Online-based questionnaire in Delivery Mode in 2,605 participants. Completed in 1 May 2018.

Timeline

1 April 2017

Primary endpoint
1 January 2018

1 May 2018

Quick facts

Lead sponsor	University Hospital Tuebingen
Status	Completed
Study type	OBSERVATIONAL
Enrollment	2,605
Start date	1 April 2017
Primary completion	1 January 2018
Estimated completion	1 May 2018
Sites	1 location across Germany

Drugs / interventions tested

Online-based questionnaire

Conditions studied

Delivery Mode — all drugs for Delivery Mode →

Sponsor

University Hospital Tuebingen

Who can join

18 and older, any sex, with Delivery Mode. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of the study is to investigate personal attitudes regarding mode of delivery among both medical health care professionals and non-professionals. The investigators are also investigating whether providing detailed information that might influence one's decision regarding mode of delivery (such as education on pelvic floor disorders or advantages or disadvantages of epidural anaesthesia) will change participants´ opinion how to determine their preferred mode of delivery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Personal Preference of Mode of Delivery. What do Urogynaecologists choose? Preliminary Results of the DECISION Study.
Bihler J, Tunn R, Reisenauer C, Pauluschke-Fröhlich J, et al · · 2017 · cited 3× · PMID 29200474 · DOI 10.1055/s-0043-120919

Verify or expand the search:

Other University Hospital Tuebingen trials

Trials by the same sponsor.

NCT07378670 — DEfeating PEnile CAncer-2 · NA · recruiting
NCT07276503 — Verification of a New Predictive Delirium Score in Adults With Elective Cardiac Valve or Bypass Surgery With Perioperati · not yet recruiting
NCT07411365 — Dual-task Cognitive-motor Telerehabilitation in Persons With PD-MCI · NA · not yet recruiting
NCT06953791 — Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Pat · Phase 2 · recruiting
NCT07378891 — Artificial-Intelligence-based Early Detection of Diabetic Retinopathy (FUNDUS AI) · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03131830 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Tuebingen
Last refreshed: 12 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03131830.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing